...
首页> 外文期刊>Cell biochemistry and function >Upregulated LncRNA‐CCAT1 promotes hepatocellular carcinoma progression by functioning as miR‐30c‐2‐3p sponge
【24h】

Upregulated LncRNA‐CCAT1 promotes hepatocellular carcinoma progression by functioning as miR‐30c‐2‐3p sponge

机译:上调的LNCRNA-CCAT1通过作为MIR-30C-2-3P海绵发挥作用促进肝细胞癌进展

获取原文
获取原文并翻译 | 示例

摘要

Hepatocellular carcinoma (HCC) is the second leading cause of cancer‐related death over the world. It is well studied that long noncoding RNA colon cancer–associated transcript‐1 (CCAT1) played important roles in variety of cancers promoting cell proliferation and metastasis by acting as a competing endogenous RNA (ceRNA) of microRNAs. However, whether CCAT1 could regulate HCC by serving as a ceRNA of microRNA remains to be revealed. In this study, we demonstrated that CCAT1 was highly expressed in HCC tissues and remarkably associated with metastasis. With a bioinformatics prediction and functional assay validation, we found a binding site of miR‐30c‐2‐3p on CCAT1, which was important for CCAT1 to promote cell proliferation. Interestingly, we further revealed a novel recognition site for miR‐30c‐2‐3p on the 3′UTR of CCNE1 by mutative method, luciferase assay, and cell viability confirmation. In general, CCAT1 regulate the expression of CCNE1 by acting as a ceRNA to sponge miR‐30c‐2‐3p in regulating the cell proliferation of HCC. These results suggest that CCAT1 may be a new therapy target for HCC in the future. Significance of the study Our findings may broaden the understanding of the role of CCAT1 in tumorigenesis and may provide a new therapy target for HCC.
机译:肝细胞癌(HCC)是世界上癌症相关死亡的第二个主要原因。它很好地研究了长期非编码RNA结肠癌相关的转录-1(CCAT1)通过作为MicroRNA的竞争内源RNA(CERNA)来促进细胞增殖和转移的各种癌症。但是,CCAT1是否可以通过用作MicroRNA的Cerna来调节HCC,仍有待揭示。在这项研究中,我们证明CCAT1在HCC组织中高度表达,并且与转移显着相关。通过生物信息学预测和功能测定验证,我们发现CCAT1上的MIR-30C-2-3P的结合位点,这对于CCAT1至关重要促进细胞增殖。有趣的是,通过突变方法,荧光素酶测定和细胞活力确认,进一步揭示了在CCNE1的3'UTR上的miR-30c-2-3p的新识别部位。通常,CCAT1通过作为CERNA来调节CCNE1的表达,以调节调节HCC的细胞增殖的MIR-30C-2-3P。这些结果表明CCAT1可能是未来HCC的新疗法目标。研究的重要性我们的发现可能会扩大对CCAT1在肿瘤内酯中的作用的理解,并且可以为HCC提供新的治疗目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号